These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23076550)

  • 1. Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.
    Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringdén O; Uhlin M; Mattsson J
    Transplantation; 2012 Nov; 94(10):1066-74. PubMed ID: 23076550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.
    Kato K; Yoshimi A; Ito E; Oki K; Hara J; Nagatoshi Y; Kikuchi A; Kobayashi R; Nagamura-Inoue T; Kai S; Azuma H; Takanashi M; Isoyama K; Kato S;
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1814-21. PubMed ID: 21664471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
    Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
    Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
    Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord blood transplantation in hematologic diseases in patients over 15 years old: long-term experience at the Pontificia Universidad Católica de Chile.
    Ramirez P; Nervi B; Bertin P; Poggi H; Lagos M; Selman C; Pizarro I; Jara V; Wiestruck A; Barriga F
    Transplant Proc; 2013; 45(10):3734-9. PubMed ID: 24315012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.
    Chen YB; Aldridge J; Kim HT; Ballen KK; Cutler C; Kao G; Liney D; Bourdeau G; Alyea EP; Armand P; Koreth J; Ritz J; Spitzer TR; Soiffer RJ; Antin JH; Ho VT
    Biol Blood Marrow Transplant; 2012 May; 18(5):805-12. PubMed ID: 22015993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
    Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis.
    Ruggeri A; Michel G; Dalle JH; Caniglia M; Locatelli F; Campos A; de Heredia CD; Mohty M; Hurtado JM; Bierings M; Bittencourt H; Mauad M; Purtill D; Cunha R; Kabbara N; Gluckman E; Labopin M; Peters C; Rocha V
    Leukemia; 2012 Dec; 26(12):2455-61. PubMed ID: 22555150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
    Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
    Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation.
    Ringdén O; Labopin M; Gorin NC; Volin L; Torelli GF; Attal M; Jouet JP; Milpied N; Socié G; Cordonnier C; Michallet M; Atienza AI; Hermine O; Mohty M;
    Br J Haematol; 2012 Apr; 157(2):220-9. PubMed ID: 22299728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.
    Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M
    Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
    Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan.
    Matsumura T; Kami M; Yamaguchi T; Yuji K; Kusumi E; Taniguchi S; Takahashi S; Okada M; Sakamaki H; Azuma H; Takanashi M; Kodo H; Kai S; Inoue-Nagamura T; Kato K; Kato S;
    Leukemia; 2012 Jul; 26(7):1482-6. PubMed ID: 22290068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.
    Sanz J; Montesinos P; Saavedra S; Lorenzo I; Senent L; Planelles D; Larrea L; Martín G; Palau J; Jarque I; Martínez J; de la Rubia J; Moscardó F; Martinez D; Gómez I; López M; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1589-95. PubMed ID: 20553927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
    Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood cells chimerism after unrelated cord blood transplantation in children: kinetics, predictive factors and impact on post-transplant outcome.
    Elkaim E; Picard C; Galambrun C; Barlogis V; Loundou A; Curtillet C; Oudin C; Thuret I; Chambost H; Michel G
    Br J Haematol; 2014 Aug; 166(4):557-65. PubMed ID: 24779895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation.
    Ballen K; Wang T; He N; Knight JM; Hong S; Frangoul H; Verdonck LF; Steinberg A; Diaz MA; LeMaistre CF; Badawy SM; Pu JJ; Hashem H; Savani B; Sharma A; Lazarus HM; Abid MB; Tay J; Rangarajan HG; Kindwall-Keller T; Freytes CO; Beitinjaneh A; Winestone LE; Gergis U; Farhadfar N; Bhatt NS; Schears RM; Gómez-Almaguer D; Aljurf M; Agrawal V; Kuwatsuka Y; Seo S; Marks DI; Lehmann L; Wood WA; Hashmi S; Saber W
    Transplant Cell Ther; 2024 Oct; 30(10):1027.e1-1027.e14. PubMed ID: 39033978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.